Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis, Japanese B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01150942
What this trial is testing

Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea

Who this might be right for
Japanese Encephalitis
Boryung Pharmaceutical Co., Ltd 205
Large-scale testing (Phase 3)Study completedNCT00596271
What this trial is testing

Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 192
Large-scale testing (Phase 3)Study completedNCT01190228
What this trial is testing

Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV

Who this might be right for
Japanese EncephalitisVaricella
Sanofi Pasteur, a Sanofi Company 454
Post-approval studies (Phase 4)Active Not RecruitingNCT06678373
What this trial is testing

Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas

Who this might be right for
Japanese Encephalitis
Liaoning Chengda Biotechnology CO., LTD 250
Large-scale testing (Phase 3)Study completedNCT03282370
What this trial is testing

Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 655
Large-scale testing (Phase 3)Study completedNCT00604708
What this trial is testing

Immunogenicity Study of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 867
Large-scale testing (Phase 3)Study completedNCT00595790
What this trial is testing

Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 374
Testing effectiveness (Phase 2)Study completedNCT03204227
What this trial is testing

Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 220
Testing effectiveness (Phase 2)Study completedNCT01943305
What this trial is testing

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Who this might be right for
Yellow FeverEncephalitis, Japanese
Singapore General Hospital 84
Post-approval studies (Phase 4)Study completedNCT01981967
What this trial is testing

Post-licensure Safety Study of IMOJEV® in Thailand

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 10,000
Testing effectiveness (Phase 2)Study completedNCT00621764
What this trial is testing

Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

Who this might be right for
Japanese EncephalitisHepatitis A
Sanofi Pasteur, a Sanofi Company 300
Testing effectiveness (Phase 2)Study completedNCT00981175
What this trial is testing

ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults

Who this might be right for
EncephalitisJapanese Encephalitis
Sanofi 202
Not applicableUnknownNCT04089436
What this trial is testing

SouthEast Asia Encephalitis Project

Who this might be right for
Encephalitis
Institut Pasteur 800
Post-approval studies (Phase 4)Study completedNCT00463476
What this trial is testing

Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine

Who this might be right for
Japanese Encephalitis
PATH 305
Large-scale testing (Phase 3)Study completedNCT02492165
What this trial is testing

Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 250
Post-approval studies (Phase 4)UnknownNCT01954810
What this trial is testing

Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children

Who this might be right for
Japanese Encephalitis
Khon Kaen University 88
Not applicableStudy completedNCT06372665
What this trial is testing

Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization

Who this might be right for
Japanese Encephalitis
Liaoning Chengda Biotechnology CO., LTD 15,357
Large-scale testing (Phase 3)Study completedNCT00595465
What this trial is testing

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 389
Post-approval studies (Phase 4)Study completedNCT06331702
What this trial is testing

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

Who this might be right for
Japanese EncephalitisMeaslesMumps+1 more
Liaoning Chengda Biotechnology CO., LTD 408
Large-scale testing (Phase 3)Study completedNCT01188343
What this trial is testing

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

Who this might be right for
Japanese EncephalitisMeaslesMumps+1 more
Sanofi Pasteur, a Sanofi Company 542
Next Page